Fluxome Sciences AS
Latest round
- Series B
Last raised
- Jul 2008
Total raised
- $20M
Investors
- 4
About Fluxome Sciences AS
Fluxome Sciences AS, founded in 2002 in Denmark, focuses on the development of advanced technologies for operational efficiency.25 million from Evolva Holding SA. The company has completed a total of four deals and does not have any subsidiaries or parent companies.com specializes in delivering innovative solutions tailored to meet the diverse needs of its clientele. The company's core product offerings revolve around advanced technologies designed to enhance operational efficiency and streamline processes across various industries. These products are developed with a focus on addressing specific challenges faced by businesses, thereby enabling them to optimize performance and drive growth. Their customer base includes a range of sectors, from technology to manufacturing, with end users benefiting from enhanced productivity and reduced operational costs. The acquisition of scientific and technical assets related to resveratrol by Evolva Holding SA will facilitate new product launches aimed at the biotechnology sector. The company is focusing on enhancing its presence in both North America and Europe while exploring potential markets in Asia by 2014.25 million will be utilized to support these initiatives.
Who invested in Fluxome Sciences AS
4 investors across 1 round
See all investors in Fluxome Sciences AS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 22, 2008
Amount
$20M
Investors
Questions about Fluxome Sciences AS
Who invested in Fluxome Sciences AS?
Fluxome Sciences AS has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fluxome Sciences AS raised?
Fluxome Sciences AS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Fluxome Sciences AS last raise money?
Fluxome Sciences AS's most recent round on record is a Series B, in Jul 2008.
What does Fluxome Sciences AS do?
Fluxome Sciences AS, founded in 2002 in Denmark, focuses on the development of advanced technologies for operational efficiency.
Where is Fluxome Sciences AS headquartered?
Fluxome Sciences AS is headquartered in Denmark.
Which VCs invest in companies like Fluxome Sciences AS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Fluxome Sciences AS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Fluxome Sciences AS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.